A spin-out is a new, independent company created from a division, project, or piece of intellectual property that originated inside a larger organization. The parent entity, whether a corporation or a university, separates part of its operations or research into a standalone business that raises its own funding, hires its own team, and operates on its own terms. The term is used interchangeably with “spin-off” in many contexts, though spin-out more commonly describes situations where the new company gains significant independence from the start.
Corporate Spin-Outs
In the corporate world, a spin-out happens when a large company decides that one of its business units would perform better as a separate entity. The parent company distributes shares of the new company to its existing shareholders, typically on a proportional basis. Under U.S. tax rules, the parent must distribute at least 80% of the voting power and 80% of each class of stock in the new company for the transaction to qualify as tax-free to shareholders. After the split, shareholders hold stock in both the original company and the newly independent one.
The parent company’s board controls the terms of the separation. Under Delaware law (where most large U.S. companies are incorporated), the parent’s directors have no legal obligation to the spin-out or its future shareholders. Their fiduciary duty runs only to the parent’s own shareholders, which means the parent negotiates the split in its own interest.
Why Companies Create Spin-Outs
The most common reason is focus. A diversified company may find that a fast-growing division is being held back by the slower-moving core business, or that Wall Street is undervaluing the company because analysts can’t cleanly evaluate two very different operations bundled together. Separating the units lets each one attract investors who understand its specific market and growth profile. Research on corporate divestitures shows that when a company spins out a business unit, the remaining parent can refocus on its core operations, and the price signals from the market become more informative for both entities.
Employee incentives also play a role. In a large conglomerate, it’s difficult to tie compensation directly to the performance of a single division. Once that division becomes its own public company with its own stock, employees can be rewarded based on results they actually control. Studies have found that this improvement in incentive alignment can increase the value of both the parent and the spin-out. Investment efficiency and productivity tend to rise after the separation, partly because capital no longer gets shuffled between unrelated business units competing for internal funding.
University and Research Spin-Outs
Spin-outs are also one of the primary ways universities turn laboratory discoveries into commercial products. A university spin-out is a new company founded to exploit knowledge or technology developed at a research institution. The founders are often the academics who did the original work, sometimes joined by outside entrepreneurs and investors who bring business experience the researchers may lack.
The process typically starts when a researcher develops something with commercial potential, such as a new drug compound, a diagnostic tool, or a software platform. The university’s technology transfer office evaluates the intellectual property, files patent applications, and negotiates terms with the founding team. The spin-out then licenses the IP from the university rather than owning it outright, and the university usually retains an equity stake or receives royalty payments in return.
Collaboration between universities and industry partners before the spin-out stage can be a major advantage. These partnerships give academics exposure to market needs and help them develop the capabilities required to build a real business, not just publish a paper. Countries and institutions that invest in knowledge transfer programs, connecting researchers with entrepreneurs and venture capital, tend to produce more successful spin-outs.
Examples in Biotech
The life sciences sector produces a high volume of university spin-outs because drug development and medical technology require the kind of deep, specialized research that happens in academic labs. Achilles Therapeutics, for instance, spun out of the Francis Crick Institute and University College London in 2016 with £13.2 million in initial backing to develop cancer therapies. Adendra Therapeutics launched in late 2021 with £40 million to work on treatments originating from Crick research. On a smaller scale, Myricx Pharma spun out from Imperial College London and the Crick in 2020 with £4.5 million in seed funding for drug discovery. These examples illustrate the wide range of initial investment sizes, from a few million for early-stage discovery work to tens of millions when the science is closer to clinical application.
How Intellectual Property Gets Transferred
The IP arrangement is one of the most important structural decisions in any spin-out. In a corporate spin-out, the parent company decides which patents, trademarks, and proprietary systems go with the new entity and which stay behind. This is negotiated entirely by the parent’s board, with the spin-out having little leverage in the process.
University spin-outs work differently. The university almost always retains ownership of the underlying patents and grants the spin-out a license to use them commercially. This protects the institution if the company fails, because the IP can be relicensed to someone else. Before any of this happens, the university’s tech transfer office will have secured the IP through patent filings and protected sensitive information using non-disclosure and materials transfer agreements. The spin-out typically receives an exclusive license in a defined field, meaning it has the sole right to commercialize the technology for a specific application, while the university may retain the ability to license it for other uses or for academic research.
The Transition Period
A newly spun-out company doesn’t have its own IT systems, accounting department, or HR processes on day one. To bridge the gap, the parent and the spin-out sign a Transition Services Agreement, a contract where the parent continues to provide essential back-office functions for a set period after the separation. Common services include IT infrastructure, access to historical data, payroll and HR support, and finance and accounting.
These agreements specify exactly what’s being provided, at what quality level, for how long, and at what cost. They also include exit criteria that define when a service is considered complete, along with termination clauses covering situations like a breach of contract or a change in business circumstances. The goal is to give the new company enough runway to build its own operations without creating an indefinite dependency on the parent. A well-structured TSA includes a governance framework with designated contacts on both sides and regular check-ins to track progress and resolve problems as they come up.
Tax Treatment for Shareholders
For corporate spin-outs that meet the requirements of Section 355 of the U.S. tax code, the distribution of new shares is tax-free to shareholders at the time they receive them. You don’t owe taxes just because shares of the spin-out appeared in your brokerage account. Your cost basis in the original parent company stock gets split between the two holdings based on their relative market values on the distribution date. Taxes come into play later, when you actually sell either stock.
The 80% distribution threshold is critical. If the parent distributes less than 80% of the spin-out’s voting stock, the transaction may not qualify for tax-free treatment, and shareholders could face an immediate tax bill. After the distribution, shareholders of the parent must collectively own more than 50% of both the voting power and total value of the spin-out’s stock for the structure to hold up under IRS rules.